Financhill
Sell
41

ALPMY Quote, Financials, Valuation and Earnings

Last price:
$9.79
Seasonality move :
2.7%
Day range:
$9.48 - $10.00
52-week range:
$9.15 - $13.14
Dividend yield:
4.81%
P/E ratio:
167.87x
P/S ratio:
1.55x
P/B ratio:
1.64x
Volume:
375.3K
Avg. volume:
285.2K
1-year change:
-14.27%
Market cap:
$17.5B
Revenue:
$11.1B
EPS (TTM):
$0.06
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $12B $11.8B $11.5B $11.2B $11.1B
Revenue Growth (YoY) 1.57% -1.52% -2.05% -2.59% -1.18%
 
Cost of Revenues $2.5B $2.3B $2.3B $2.1B $2B
Gross Profit $9.4B $9.5B $9.3B $9.1B $9.1B
Gross Profit Margin 78.73% 80.31% 80.48% 81.01% 81.76%
 
R&D Expenses $2.1B $2.1B $2.2B $2B $2B
Selling, General & Admin $4.6B $4.8B $4.9B $4.7B $5.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $7.2B $8.2B $8.1B $8.1B $9B
Operating Income $2.3B $1.3B $1.2B $974.3M $131.3M
 
Net Interest Expenses -- -- -- $5M $3.8M
EBT. Incl. Unusual Items $2.3B $1.4B $1.4B $980.2M $173M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $459.5M $233.3M $292.2M $249.2M $54.9M
Net Income to Company $2.3B $1.4B $1.4B $980.2M $173M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $1.1B $1.1B $731M $118.1M
 
Basic EPS (Cont. Ops) $0.96 $0.61 $0.60 $0.40 $0.07
Diluted EPS (Cont. Ops) $0.96 $0.61 $0.60 $0.40 $0.07
Weighted Average Basic Share $1.9B $1.9B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.9B $1.9B $1.9B $1.8B $1.8B
 
EBITDA $2.9B $2.1B $2.2B $1.8B $1.4B
EBIT $2.3B $1.4B $1.4B $1B $256.2M
 
Revenue (Reported) $12B $11.8B $11.5B $11.2B $11.1B
Operating Income (Reported) $2.3B $1.3B $1.2B $974.3M $131.3M
Operating Income (Adjusted) $2.3B $1.4B $1.4B $1B $256.2M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $2.9B $3B $2.9B $2.7B $3B
Revenue Growth (YoY) -6.17% 4.45% -1.11% -7.25% 11.06%
 
Cost of Revenues $554.4M $568.5M $685.9M $502.5M $584.6M
Gross Profit $2.3B $2.4B $2.3B $2.2B $2.5B
Gross Profit Margin 80.57% 80.92% 76.72% 81.61% 80.74%
 
R&D Expenses $532.4M $532.7M $571.2M $470.7M $556.9M
Selling, General & Admin $1.1B $1.3B $1.2B $1.2B $1.3B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.7B $2.1B $2B $1.9B $2.1B
Operating Income $565.4M $327M $251.8M $328.3M $306.7M
 
Net Interest Expenses $5.4M $2.4M $11.3M -- $1M
EBT. Incl. Unusual Items $559.8M $327.3M $244.5M $341.4M $323.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $91.3M $47M $53M $100M $82.7M
Net Income to Company $559.8M $327.3M $244.5M $341.4M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $468.5M $280.4M $191.5M $241.4M $241.2M
 
Basic EPS (Cont. Ops) $0.25 $0.15 $0.10 $0.13 $0.13
Diluted EPS (Cont. Ops) $0.25 $0.15 $0.10 $0.13 $0.13
Weighted Average Basic Share $1.9B $1.9B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.9B $1.9B $1.8B $1.8B $1.8B
 
EBITDA $735.9M $508.8M $547.5M $530.6M $675.2M
EBIT $568.7M $343M $263M $361.2M $352.7M
 
Revenue (Reported) $2.9B $3B $2.9B $2.7B $3B
Operating Income (Reported) $565.4M $327M $251.8M $328.3M $306.7M
Operating Income (Adjusted) $568.7M $343M $263M $361.2M $352.7M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $11.8B $11.9B $11.5B $11B $11.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.5B $2.3B $2.4B $2B $2.1B
Gross Profit $9.3B $9.6B $9.1B $9.1B $9.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.1B $2.1B $2.2B $1.9B $2.1B
Selling, General & Admin $4.6B $4.9B $4.8B $4.7B $5.2B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $7.2B $8.5B $8B $8B $9.2B
Operating Income $2.1B $1B $1.1B $1B $103M
 
Net Interest Expenses -- -- -- -- $11.9M
EBT. Incl. Unusual Items $2.1B $1.1B $1.3B $1B $150.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $386.8M $189.6M $300.2M $291.6M $45M
Net Income to Company $2.1B $1.1B $1.3B $1.1B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.7B $950.5M $1B $754M $105.2M
 
Basic EPS (Cont. Ops) $0.93 $0.51 $0.56 $0.42 $0.06
Diluted EPS (Cont. Ops) $0.93 $0.51 $0.56 $0.42 $0.06
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $2.8B $1.9B $2.2B $1.8B $1.5B
EBIT $2.1B $1.2B $1.4B $1.1B $242.1M
 
Revenue (Reported) $11.8B $11.9B $11.5B $11B $11.4B
Operating Income (Reported) $2.1B $1B $1.1B $1B $103M
Operating Income (Adjusted) $2.1B $1.2B $1.4B $1.1B $242.1M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $2.9B $3B $2.9B $2.7B $3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $554.4M $568.5M $685.9M $502.5M $584.6M
Gross Profit $2.3B $2.4B $2.3B $2.2B $2.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $532.4M $532.7M $571.2M $470.7M $556.9M
Selling, General & Admin $1.1B $1.3B $1.2B $1.2B $1.3B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.7B $2.1B $2B $1.9B $2.1B
Operating Income $565.4M $327M $251.8M $328.3M $306.7M
 
Net Interest Expenses $5.4M $2.4M $11.3M -- $1M
EBT. Incl. Unusual Items $559.8M $327.3M $244.5M $341.4M $323.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $91.3M $47M $53M $100M $82.7M
Net Income to Company $559.8M $327.3M $244.5M $341.4M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $468.5M $280.4M $191.5M $241.4M $241.2M
 
Basic EPS (Cont. Ops) $0.25 $0.15 $0.10 $0.13 $0.13
Diluted EPS (Cont. Ops) $0.25 $0.15 $0.10 $0.13 $0.13
Weighted Average Basic Share $1.9B $1.9B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.9B $1.9B $1.8B $1.8B $1.8B
 
EBITDA $735.9M $508.8M $547.5M $530.6M $675.2M
EBIT $568.7M $343M $263M $361.2M $352.7M
 
Revenue (Reported) $2.9B $3B $2.9B $2.7B $3B
Operating Income (Reported) $565.4M $327M $251.8M $328.3M $306.7M
Operating Income (Adjusted) $568.7M $343M $263M $361.2M $352.7M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $2.9B $3B $2.6B $2.8B $2.2B
Short Term Investments $87.5M $50.4M $174.5M $148.5M $190.2M
Accounts Receivable, Net $3.2B $3.1B $3.1B $3.2B $3.5B
Inventory $1.4B $1.5B $1.3B $1.3B $1.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $167M $178.2M $237.6M $243.4M $213M
Total Current Assets $8B $7.9B $7.6B $7.9B $7.9B
 
Property Plant And Equipment $2.5B $2.4B $2.2B $2.1B $1.9B
Long-Term Investments -- -- -- -- --
Goodwill $2.6B $2.6B $2.5B $2.5B $2.8B
Other Intangibles $6.7B $5.9B $5.1B $4.2B $9.6B
Other Long-Term Assets $94.2M $89.9M $78.1M $77.2M $122.9M
Total Assets $21.4B $20.6B $19.1B $18.4B $23.6B
 
Accounts Payable $1.6B $1.1B $1.1B $1.1B $1.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.4B $2.6B $2.6B $2.9B $3.1B
Total Current Liabilities $7.4B $5.4B $5.6B $5.4B $8.5B
 
Long-Term Debt -- -- -- $375.3M $3B
Capital Leases -- -- -- -- --
Total Liabilities $9.5B $8B $7.1B $7.1B $13B
 
Common Stock $953.1M $933.7M $843.9M $773M $680.5M
Other Common Equity Adj -- -- -- -- --
Common Equity $11.9B $12.6B $12B $11.3B $10.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $11.9B $12.6B $12B $11.3B $10.5B
 
Total Liabilities and Equity $21.4B $20.6B $19.1B $18.4B $23.6B
Cash and Short Terms $3B $3B $2.8B $3B $2.4B
Total Debt -- -- -- $938.1M $6.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.7B $2.8B $2.5B $2.2B $2.1B
Short Term Investments $72.9M $89.3M $221.1M $198.5M $253.9M
Accounts Receivable, Net $3.1B $3.2B $3.1B $3.3B $3.9B
Inventory $1.5B $1.3B $1.2B $1.4B $1.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $215.1M $215M $235.2M $225.3M $298.6M
Total Current Assets $7.8B $7.8B $7.3B $7.5B $8.4B
 
Property Plant And Equipment $2.5B $2.4B $1.9B $2B $2.2B
Long-Term Investments -- -- -- -- --
Goodwill $2.6B $2.5B $2.4B $2.7B $2.8B
Other Intangibles $6.5B $5.7B $4.5B $10.3B $9.3B
Other Long-Term Assets $96.5M $82.8M $81.8M $58.4M $185.9M
Total Assets $21.2B $20.2B $17.9B $23.7B $24.2B
 
Accounts Payable $1.1B $996.6M $1B $985.7M $1.1B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.5B $2.8B $2.6B $3.1B $3.4B
Total Current Liabilities $5.8B $5B $5.3B $7.8B $7.7B
 
Long-Term Debt -- -- -- $3.2B $4.3B
Capital Leases -- -- -- -- --
Total Liabilities $8.6B $7.5B $6.5B $12.7B $13.5B
 
Common Stock $974.7M $920.1M $713M $689.5M $721.2M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $12.6B $12.7B $11.4B $11B $10.7B
 
Total Liabilities and Equity $21.2B $20.2B $17.9B $23.7B $24.2B
Cash and Short Terms $2.8B $2.9B $2.7B $2.4B $2.3B
Total Debt -- -- -- $6B --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $2.3B $1.4B $1.4B $980.2M $173M
Depreciation & Amoritzation $610.9M $685.3M $709.8M $783.1M $1.1B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$150.8M $209M -$71.3M -$35.9M -$387.7M
Change in Inventories -$55.6M -$21.9M $214.3M -$52.5M -$416M
Cash From Operations $2B $2.9B $2.3B $2.4B $1.2B
 
Capital Expenditures $716.6M $730.5M $681M $655.7M $571.7M
Cash Acquisitions -$3B -$140.7M -$6M -- -$5.4B
Cash From Investing -$3.6B -$772.5M -$556M -$625.8M -$5.9B
 
Dividends Paid (Ex Special Dividend) -$676.6M -$718.4M -$759.3M -$743.2M -$808.4M
Special Dividend Paid
Long-Term Debt Issued $3B $754.7M -- $370.3M $3.3B
Long-Term Debt Repaid -- -$1.9B -$267.2M -$370.3M -$175.9M
Repurchase of Common Stock -$486.7M -$86.4M -$451.8M -$448.5M -$74.4M
Other Financing Activities -$7.8M -$21.4M -$22.5M -$23.8M -$114.6M
Cash From Financing $1.7B -$2.2B -$1.9B -$1.4B $4.3B
 
Beginning Cash (CF) $2.9B $3B $2.9B $2.3B $2.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $122M -$42.7M -$189.4M $352.8M -$410.7M
Ending Cash (CF) $2.9B $3.1B $2.8B $2.8B $2.3B
 
Levered Free Cash Flow $1.3B $2.2B $1.6B $1.8B $623.5M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $57.8M -$201.6M -$75.1M -$298.2M -$325.6M
Depreciation & Amoritzation $166.8M $167.4M $194.3M $196.3M $354.3M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $119.9M $157.5M $84.5M $238.7M -$171.6M
Change in Inventories -$46.5M -$7.2M $62.4M -$71.3M -$113.9M
Cash From Operations $476.5M $738.8M $455.9M $922.3M $514.6M
 
Capital Expenditures $196.3M $166.9M $160.4M $227.1M $147.9M
Cash Acquisitions -$2.8B $2M -$171K -- -$124.7M
Cash From Investing -$2.9B -$124M -$137.3M -$187.6M -$283.1M
 
Dividends Paid (Ex Special Dividend) -$322.3K $10.8M -$9.4M -$31.4M -$18.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -$11.3M -- $15.6M $78.7M
Long-Term Debt Repaid -- -$401.7M -- -$370.3M -$130.7M
Repurchase of Common Stock -$136.7M -$78M -$445.5M -$373.6M -$1.7M
Other Financing Activities $1.4M -$5M -$6.4M -$7.7M -$62.9M
Cash From Financing $2.8B -$524.2M -$684M -$802.4M $306M
 
Beginning Cash (CF) $2.6B $2.9B $3.1B $2.7B $1.7B
Foreign Exchange Rate Adjustment -$16.6M $96.1M $63.2M $51.3M $9.3M
Additions / Reductions $391.7M $90.6M -$365.5M -$67.6M $537.6M
Ending Cash (CF) $2.9B $3.1B $2.8B $2.8B $2.3B
 
Levered Free Cash Flow $280.2M $571.9M $295.5M $695.2M $366.7M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $2.1B $1.1B $1.3B $1.1B --
Depreciation & Amoritzation $623.4M $683.8M $828.6M $667.9M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$73.5M $149.3M -$17.9M $154.4M --
Change in Inventories -$53.6M $83.3M $170.6M -$206.3M --
Cash From Operations $2.2B $3.1B $2.3B $2.1B $1.2B
 
Capital Expenditures $930.2M $603.3M $640M $634M $452.4M
Cash Acquisitions -$2.9B -$131.1M -$48K -- -$5.4B
Cash From Investing -$3.7B -$701.9M -$511.1M -$567.7M --
 
Dividends Paid (Ex Special Dividend) -$695.8M -$728.7M -$756.3M -$783.5M -$415.6M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$494.9M -$84.8M -$526.7M -$445.2M --
Other Financing Activities -$9.1M -$21.2M -$22M -$26.1M --
Cash From Financing $1.4B -$1.9B -$1.9B $113.7M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$191.7M $462.9M -$84.9M $1.7B --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.2B $2.5B $1.7B $1.5B --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.4B $1.4B $980.2M $173M --
Depreciation & Amoritzation $685.3M $709.8M $783.1M $1.1B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $209M -$71.3M -$35.9M -$387.7M --
Change in Inventories -$21.9M $214.3M -$52.5M -$416M --
Cash From Operations $2.9B $2.3B $2.4B $1.2B --
 
Capital Expenditures $730.5M $681M $655.7M $571.7M --
Cash Acquisitions -$140.7M -$6M -- -$5.4B --
Cash From Investing -$772.5M -$556M -$625.8M -$5.9B --
 
Dividends Paid (Ex Special Dividend) -$718.4M -$759.3M -$743.2M -$808.4M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $754.7M -- $370.3M $3.3B --
Long-Term Debt Repaid -$1.9B -- -$370.3M -$175.9M --
Repurchase of Common Stock -$86.4M -$451.8M -$448.5M -$74.4M --
Other Financing Activities -$21.4M -$22.5M -$23.8M -$114.6M --
Cash From Financing -$2.2B -$1.9B -$1.4B $4.3B --
 
Beginning Cash (CF) $10.8B $11.7B $10.2B $10.9B --
Foreign Exchange Rate Adjustment $115.7M $99.1M $97.8M $125.5M --
Additions / Reductions -$42.7M -$189.4M $352.8M -$410.7M --
Ending Cash (CF) $10.9B $11.5B $10.5B $10.5B --
 
Levered Free Cash Flow $2.2B $1.6B $1.8B $623.5M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 14.24% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 22.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock